Natasha Gilbert is a freelance writer who has spent a decade covering the environment, biology, agriculture and education for outlets including The Guardian, National Public Radio and Scientific American. She is a former staff reporter for Nature. She has an M.Sc. in philosophy of science from the London School of Economics and a B.Sc. in environmental biology from the University of Reading in the U.K. She is a native Londoner living in Washington, D.C.
Natasha Gilbert
From this contributor
Snapshots reveal striking changes in adult brain over time
The most detailed depiction of an individual brain to date shows that the connections in a person's brain vary significantly over the course of a year and a half.
Snapshots reveal striking changes in adult brain over time
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.